Researchers report early results suggesting CAR‑T cell therapy could improve mobility for people with stiff-person syndrome (SPS), a rare autoimmune condition that affects the central nervous system and causes rigidity and painful muscle spasms. Across outlets, trial participants are described as experiencing reductions in stiffness and improved movement, though investigators urge caution and stress that the approach is not yet a cure.
Several reports frame the development in relation to Céline Dion, whose SPS has brought wider attention to the condition. The Guardian and The Independent focus on patients benefiting in everyday life, including returning to work and resuming hobbies, while also noting the lack of an existing cure. By contrast, the Mirror presents the research more sweepingly, implying scientists are close to finding a cure and referencing a potential genetic therapy element said to halt “statue” attacks.
Overall, coverage agrees on the condition’s severity and incurability, while differing in how strongly they characterize the emerging treatment and what additional therapy details they emphasize.
